Numbers
Claude View
Financial Analysis
Sarla Performance Fibers trades at ₹84 per share with a market capitalization of ₹705 Cr, representing a P/E of 11.9x on trailing earnings and a 3.6% dividend yield. The stock sits 34% below its 52-week high of ₹128, offering a price-to-book of 1.36x on a business that generated ₹62 Cr in net profit over the trailing twelve months and posted its best annual ROCE (15%) in over a decade during FY2025. Yet the most recent quarter, Q3 FY2026, showed a sharp earnings collapse that demands scrutiny.
CMP (₹)
Mkt Cap (₹ Cr)
P/E (TTM)
Price/Book
ROCE %
ROE %
Dividend Yield %
52W High (₹)
Revenue and Earnings Power
Sarla's revenue has been range-bound between ₹260-430 Cr over the past twelve years, a trajectory that speaks of a mature niche player rather than a growth compounder. The FY2022 spike to ₹431 Cr coincided with post-pandemic yarn demand and price inflation, but revenue retreated to ₹383-387 Cr in FY2023-24 before recovering to ₹425 Cr in FY2025. Net profit swung between ₹21 Cr and ₹62 Cr in this period, demonstrating the operating leverage inherent in a manufacturing business with substantial fixed costs.
FY2025 marked a standout year for margins. Operating margin hit 21.6%, the highest in the twelve-year series alongside FY2021, while net margin at 14.6% was the best on record. The question is whether this reflects genuine structural improvement in product mix or simply a favorable raw material cycle that will mean-revert.
Quarterly Trajectory
The quarterly data tells a story of acceleration through FY2024-25 followed by a sudden reversal. Revenue peaked at ₹113.9 Cr in Q2 FY2025 before declining to ₹89.2 Cr by Q3 FY2026. More alarmingly, Q3 FY2026 operating profit crashed to just ₹2.6 Cr, implying operating expenses surged or realizations collapsed. Net profit of ₹5.0 Cr was only possible because of ₹12.3 Cr in other income, likely from investments. Q1 FY2026 showed a similar pattern: operating profit of just ₹10.8 Cr was masked by ₹22.7 Cr in other income delivering ₹22.3 Cr in net profit.
Cash Generation
FY25 Op. Cash Flow (₹ Cr)
FY25 Free Cash Flow (₹ Cr)
FCF Margin %
FCF Yield %
Cash generation has been lumpy. FY2023 was the standout year with ₹102 Cr in operating cash flow, but FY2024 collapsed to ₹31 Cr despite similar profitability. FY2025 recovered to ₹62 Cr. Free cash flow of ₹42 Cr in FY2025 translates to a 6% yield on the current market cap, reasonable for a small-cap textile company. But the volatility in cash flows, swinging from ₹3 Cr FCF in FY2022 to ₹55 Cr in FY2023, underscores the working capital intensity of this business.
Balance Sheet Strength
The deleveraging story is compelling. Debt-to-equity dropped from 1.16x in FY2016 to a low of 0.28x in FY2023, though it has crept back up to 0.37x in FY2025 as borrowings rose to ₹181 Cr. Total equity now stands at ₹490 Cr (book value ₹61.6 per share), anchored by ₹482 Cr in reserves. The balance sheet also holds ₹286 Cr in investments as of FY2025, up sharply from ₹51 Cr in FY2022. These appear to be financial investments and explain the growing contribution of other income to the bottom line.
A striking shift has occurred on the asset side. Investments have grown from ₹51 Cr to ₹321 Cr in just four years, while fixed assets have actually declined from ₹232 Cr to ₹231 Cr. This is a business that is increasingly behaving like an investment company rather than a manufacturing growth story. With CWIP at zero, there is no visible capex pipeline for capacity expansion.
Working Capital and Efficiency
The cash conversion cycle remains stubbornly high for a yarn manufacturer. Inventory days jumped back to 191 in FY2025 after improving to 155 in FY2024, suggesting either voluntary stocking or slower offtake. Debtor days at 81 are manageable, but the overall CCC of 211 days means more than half a year's worth of revenue is trapped in working capital at any given time.
ROCE has oscillated between 7% and 15% over the past decade, averaging roughly 10-11%. The FY2025 reading of 15% is the cycle peak, driven by the best operating margins in years. The three-year average ROE of 9.3% (per Screener) tells the longer story: this is not a business that compounds capital at high rates.
Shareholding Pattern
Promoter holding has inched up from 56.5% to 57.1% over the past two years through open market purchases, a modest positive signal. Institutional interest remains negligible: FIIs hold under 1%, DIIs under 1%, and the stock remains overwhelmingly a retail-and-promoter story. The number of shareholders peaked at 40,182 in Sep 2024 and has since declined to 35,815, suggesting some retail exit.
Peer Comparison
Among synthetic fiber peers, Sarla stands out on two dimensions: margins and returns. Its FY2025 operating margin of 21.6% is roughly three to four times what Filatex (6.1%), Century Enka (5.7%), and Indo Rama (4.2%) managed on far larger revenue bases. ROCE at 14.9% dwarfs every peer except the diversified conglomerate Grasim. This premium profitability in a commodity-adjacent sector speaks to Sarla's positioning in specialty and performance yarns rather than bulk commodity synthetics. The P/E of 11.9x is in line with Filatex (10.6x) and Century Enka (12.9x), meaning the market is not yet paying for the margin advantage.
Dividend Track Record
The dividend policy is inconsistent. Sarla paid nothing in FY2020-21 (Covid), resumed in FY2022, skipped FY2023-24 entirely, and returned with ₹40 Cr in FY2025, the largest payout in its history. At the current price, the trailing yield of 3.6% is attractive for a small-cap textile stock. The company announced a dividend payable on July 25, 2025, suggesting the board views FY2025's earnings quality as sustainable. However, the stop-and-start pattern makes it impossible to model Sarla as a reliable income stock.
Earnings Quality: Operating vs Other Income
This is the most important chart in this analysis. While FY2025 annual numbers looked healthy with ₹92 Cr operating profit versus ₹23 Cr other income, the TTM picture has shifted dramatically. Other income surged to ₹48 Cr on a trailing basis, driven by returns on the ₹321 Cr investment portfolio. In Q1 FY2026, other income of ₹22.7 Cr actually exceeded operating profit of ₹10.8 Cr. The company is effectively running a yarn business as a side hustle to an investment portfolio, a dynamic that flatters headline earnings but raises questions about the sustainability and quality of reported profits.
What the Numbers Confirm, Contradict, and What to Watch
The numbers confirm that Sarla occupies a defensible niche in specialty performance yarns, delivering margins that its bulk-commodity peers cannot match. The balance sheet is conservatively managed with debt-to-equity well under 0.5x and a growing investment portfolio that provides a floor under earnings even during operating downturns. What the numbers contradict is any growth narrative: revenue has barely budged over a decade in real terms, CWIP is zero, and the company appears to be choosing financial investments over capacity expansion. The Q3 FY2026 operating margin collapse to 2.9% needs careful watching next quarter. If it reflects transient raw material or demand disruption, the mean-reversion case for ₹84 is strong at 11.9x P/E with a 3.6% yield. If it signals structural demand erosion in Sarla's specialty yarn verticals, the market has not priced in the risk.